Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation
Le, Dean A.
Augustinack, Jean C.
Hyman, Bradley T.
Flavell, Richard A.
Moskowitz, Michael A.
MetadataShow full item record
CitationLe, D. A., Y. Wu, Z. Huang, K. Matsushita, N. Plesnila, J. C. Augustinack, B. T. Hyman, et al. 2002. “Caspase Activation and Neuroprotection in Caspase-3- Deficient Mice after in Vivo Cerebral Ischemia and in Vitro Oxygen Glucose Deprivation.” Proceedings of the National Academy of Sciences 99 (23): 15188–93. https://doi.org/10.1073/pnas.232473399.
AbstractCaspase-3 is a major cell death effector protease in the adult and neonatal nervous system. We found a greater number and higher density of cells in the cortex of caspase-3(-/-) adult mice, consistent with a defect in developmental cell death. Caspase-3(-/-) mice were also more resistant to ischemic stress both in vivo and in vitro. After 2 h of ischemia and 48 h of reperfusion, cortical infarct volume was reduced by 55%, and the density of terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling-positive cells was decreased by 36% compared with wild type. When subjected to oxygen-glucose deprivation (2 h), cortical neurons cultured from mice deficient in caspase-3 expression were also more resistant to cell death by 59%. Mutant brains showed caspase-specific poly(ADP-ribose) polymerase cleavage product (85-kDa fragment) in vivo and in vitro, suggesting redundant mechanisms and persistence of caspase-mediated cell death. In the present study, we found that caspase-8 mediated poly(ADP-ribose) polymerase cleavage in caspase-3(-/-) neurons in vivo and in vitro. In addition, mutant neurons showed no evidence of compensatory activation by caspase-6 or caspase-7 after ischemia. Taken together, these data extend the pharmacological evidence supporting an important role for caspase-3 and caspase-8 as cell death mediators in mammalian cortex and indicate the potential advantages of targeting more than a single caspase family member to treat ischemic cell injury.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41483515
- HMS Scholarly Articles